Equitec Proprietary Markets, LLC
- SEC CIK
- 0001143261
- Latest filing
- Jul 20, 2026
PMCB holding history
PharmaCyte Biotech, Inc. in every 13F filed by Equitec Proprietary Markets, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PMCB overviewAll 13F holders of PMCBFull Q2 2026 holdings
- Shares (Q2 2026)
- 22,227
- Value
- $17.1K
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 22,227 | $17.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 22,227 | $14.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 22,227 | $16.1K | 0.1% | −60,500−73.1% | Reduced | Holders |
| Q3 2025 | 82,727 | $80.2K | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2025 | 82,727 | $90.2K | 0.4% | 00.0% | Unchanged | Holders |
| Q1 2025 | 82,727 | $103.4K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2024 | 82,727 | $129.9K | 0.9% | 00.0% | Unchanged | Holders |
| Q3 2024 | 82,727 | $158.0K | 1.4% | 00.0% | Unchanged | Holders |
| Q2 2024 | 82,727 | $162.1K | 1.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 82,727 | $196.1K | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2023 | 82,727 | $178.7K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2023 | 82,727 | $173.7K | 0.2% | +21,312+34.7% | Added | Holders |
| Q2 2023 | 61,415 | $175.6K | 0.1% | −269,279−81.4% | Reduced | Holders |
| Q1 2023 | 330,694 | $962.3K | 0.9% | 00.0% | Unchanged | Holders |
| Q4 2022 | 330,694 | $968.9K | 0.6% | 00.0% | Unchanged | Holders |
| Q3 2022 | 330,694 | $794.0K | 0.4% | −12,300−3.6% | Reduced | Holders |
| Q2 2022 | 342,994 | $768.0K | 0.4% | +33,700+10.9% | Added | Holders |
| Q1 2022 | 309,294 | $711.0K | 0.3% | +50,600+19.6% | Added | Holders |
| Q4 2021 | 258,694 | $647.0K | 0.3% | +258,694 | New | Holders |